Dirk J. Ruiter, Ph.D. - Publications

Affiliations: 
Anatomy Radboudumc 

85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Kleinnijenhuis M, van Mourik T, Norris DG, Ruiter DJ, van Cappellen van Walsum AM, Barth M. Diffusion tensor characteristics of gyrencephaly using high resolution diffusion MRI in vivo at 7T. Neuroimage. 109: 378-87. PMID 25585019 DOI: 10.1016/J.Neuroimage.2015.01.001  0.666
2010 van Engen-van Grunsven AC, van Dijk MC, Ruiter DJ, Klaasen A, Mooi WJ, Blokx WA. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. The American Journal of Surgical Pathology. 34: 1436-41. PMID 20871217 DOI: 10.1097/Pas.0B013E3181F0A749  0.357
2010 van Kilsdonk JW, van Kempen LC, van Muijen GN, Ruiter DJ, Swart GW. Soluble adhesion molecules in human cancers: sources and fates. European Journal of Cell Biology. 89: 415-27. PMID 20227133 DOI: 10.1016/J.Ejcb.2009.11.026  0.304
2010 Blokx WA, van Dijk MC, Ruiter DJ. Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects. Histopathology. 56: 121-32. PMID 20055910 DOI: 10.1111/J.1365-2559.2009.03452.X  0.33
2008 Boone B, Blokx W, De Bacquer D, Lambert J, Ruiter D, Brochez L. The role of VEGF-C staining in predicting regional metastasis in melanoma Virchows Archiv. 453: 257-265. PMID 18679715 DOI: 10.1007/S00428-008-0641-6  0.322
2008 van Kempen LC, Rijntjes J, Mamor-Cornelissen I, Vincent-Naulleau S, Gerritsen MJ, Ruiter DJ, van Dijk MC, Geffrotin C, van Muijen GN. Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma. International Journal of Cancer. Journal International Du Cancer. 122: 1019-29. PMID 17957794 DOI: 10.1002/Ijc.23147  0.379
2007 De Vries IJ, Bernsen MR, van Geloof WL, Scharenborg NM, Lesterhuis WJ, Rombout PD, Van Muijen GN, Figdor CG, Punt CJ, Ruiter DJ, Adema GJ. In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients. Cancer Immunology, Immunotherapy : Cii. 56: 1667-76. PMID 17440724 DOI: 10.1007/S00262-007-0304-5  0.331
2007 Küsters B, Kats G, Roodink I, Verrijp K, Wesseling P, Ruiter DJ, de Waal RM, Leenders WP. Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis. Oncogene. 26: 5808-15. PMID 17353901 DOI: 10.1038/Sj.Onc.1210360  0.341
2007 Spatz A, Gimotty PA, Cook MG, van den Oord JJ, Desai N, Eggermont AM, Keilholz U, Ruiter DJ, Mihm MC. Protective effect of a brisk tumor infiltrating lymphocyte infiltrate in melanoma: An EORTC melanoma group study Journal of Clinical Oncology. 25: 8519-8519. DOI: 10.1200/Jco.2007.25.18_Suppl.8519  0.355
2005 Clarijs R, van Dijk M, Ruiter DJ, de Waal RM. Functional and morphologic analysis of the fluid-conducting meshwork in xenografted cutaneous and primary uveal melanoma. Investigative Ophthalmology & Visual Science. 46: 3013-20. PMID 16123395 DOI: 10.1167/Iovs.04-0876  0.316
2005 de Vries IJ, Bernsen MR, Lesterhuis WJ, Scharenborg NM, Strijk SP, Gerritsen MJ, Ruiter DJ, Figdor CG, Punt CJ, Adema GJ. Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5779-87. PMID 16110035 DOI: 10.1200/Jco.2005.06.478  0.309
2005 van Kempen LC, van Muijen GN, Ruiter DJ. Stromal responses in human primary melanoma of the skin. Frontiers in Bioscience : a Journal and Virtual Library. 10: 2922-31. PMID 15970546 DOI: 10.2741/1748  0.331
2005 de Wit NJ, Rijntjes J, Diepstra JH, van Kuppevelt TH, Weidle UH, Ruiter DJ, van Muijen GN. Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. British Journal of Cancer. 92: 2249-61. PMID 15900300 DOI: 10.1038/Sj.Bjc.6602612  0.343
2005 Van Damme PA, de Wilde PC, Koot RA, Bruaset I, Slootweg PJ, Ruiter DJ. Juxtacortical chondrosarcoma of the mandible: report of a unique case and review of the literature. International Journal of Oral and Maxillofacial Surgery. 34: 94-8. PMID 15617976 DOI: 10.1016/J.Ijom.2004.02.011  0.305
2005 Blokx WA, Ruiter DJ, Verdijk MA, de Wilde PC, Willems RW, de Jong EM, Ligtenberg MJ. INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor. The American Journal of Surgical Pathology. 29: 125-30. PMID 15613867 DOI: 10.1097/01.Pas.0000146003.00727.7A  0.307
2005 de Wit NJ, Cornelissen IM, Diepstra JH, Weidle UH, Ruiter DJ, van Muijen GN. The MMA1 gene family of cancer-testis antigens has multiple alternative splice variants: characterization of their expression profile, the genomic organization, and transcript properties. Genes, Chromosomes & Cancer. 42: 10-21. PMID 15472897 DOI: 10.1002/Gcc.20107  0.31
2004 van Kempen LC, Rijntjes J, Claes A, Blokx WA, Gerritsen MJ, Ruiter DJ, van Muijen GN. Type I collagen synthesis parallels the conversion of keratinocytic intraepidermal neoplasia to cutaneous squamous cell carcinoma. The Journal of Pathology. 204: 333-9. PMID 15476275 DOI: 10.1002/Path.1659  0.333
2004 Leenders WPJ, Küsters B, Verrijp K, Maass C, Wesseling P, Heerschap A, Ruiter D, Ryan A, De Waal R. Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option Clinical Cancer Research. 10: 6222-6230. PMID 15448011 DOI: 10.1158/1078-0432.Ccr-04-0823  0.323
2004 Peeters CF, Westphal JR, de Waal RM, Ruiter DJ, Wobbes T, Ruers TJ. Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients. International Journal of Cancer. Journal International Du Cancer. 112: 554-9. PMID 15382035 DOI: 10.1002/Ijc.20374  0.327
2004 de Groot-Besseling RR, Ruers TJ, van Kraats AA, Poelen GJ, Ruiter DJ, de Waal RM, Westphal JR. Anti-tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model. International Journal of Cancer. Journal International Du Cancer. 112: 329-34. PMID 15352048 DOI: 10.1002/Ijc.20400  0.307
2004 de Wit NJ, van Muijen GN, Ruiter DJ. Immunohistochemistry in melanocytic proliferative lesions. Histopathology. 44: 517-41. PMID 15186267 DOI: 10.1111/J.1365-2559.2004.01860.X  0.366
2004 Bernsen MR, Diepstra JH, van Mil P, Punt CJ, Figdor CG, van Muijen GN, Adema GJ, Ruiter DJ. Presence and localization of T-cell subsets in relation to melanocyte differentiation antigen expression and tumour regression as assessed by immunohistochemistry and molecular analysis of microdissected T cells. The Journal of Pathology. 202: 70-9. PMID 14694523 DOI: 10.1002/Path.1494  0.343
2003 van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM. The tumor microenvironment: a critical determinant of neoplastic evolution. European Journal of Cell Biology. 82: 539-48. PMID 14703010 DOI: 10.1078/0171-9335-00346  0.354
2003 Bernsen MR, Smetsers TF, van de Westerlo E, Ruiter DJ, HÃ¥kansson L, Gustafsson B, Van Kuppevelt TH, Krysander L, Rettrup B, HÃ¥kansson A. Heparan sulphate epitope-expression is associated with the inflammatory response in metastatic malignant melanoma. Cancer Immunology, Immunotherapy : Cii. 52: 780-3. PMID 13680194 DOI: 10.1007/S00262-003-0421-8  0.362
2003 Ruiter DJ, van Dijk MC, Ferrier CM. Current diagnostic problems in melanoma pathology. Seminars in Cutaneous Medicine and Surgery. 22: 33-41. PMID 12773012 DOI: 10.1053/Sder.2003.50003  0.328
2003 Leenders W, Küsters B, Pikkemaat J, Wesseling P, Ruiter D, Heerschap A, Barentsz J, De Waal RMW. Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in Gd-DTPA-enhanced MRI International Journal of Cancer. 105: 437-443. PMID 12712432 DOI: 10.1002/Ijc.11102  0.314
2003 Bernsen MR, HÃ¥kansson L, Gustafsson B, Krysander L, Rettrup B, Ruiter D, HÃ¥kansson A. On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases. British Journal of Cancer. 88: 424-31. PMID 12569387 DOI: 10.1038/Sj.Bjc.6600703  0.342
2003 Zendman AJ, Ruiter DJ, Van Muijen GN. Cancer/testis-associated genes: identification, expression profile, and putative function. Journal of Cellular Physiology. 194: 272-88. PMID 12548548 DOI: 10.1002/Jcp.10215  0.33
2003 Clarijs R, Ruiter DJ, De Waal RM. Pathophysiological implications of stroma pattern formation in uveal melanoma. Journal of Cellular Physiology. 194: 267-71. PMID 12548547 DOI: 10.1002/Jcp.10214  0.366
2003 van Dijk M, Sprenger S, Rombout P, Marres H, Kaanders J, Jeuken J, Ruiter D. Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization. Genes, Chromosomes & Cancer. 36: 151-8. PMID 12508243 DOI: 10.1002/Gcc.10156  0.315
2002 Ferrier CM, Van Geloof WL, Straatman H, Van De Molengraft FJ, Van Muijen GN, Ruiter DJ. Spitz naevi may express components of the plasminogen activation system. The Journal of Pathology. 198: 92-9. PMID 12210068 DOI: 10.1002/Path.1167  0.332
2002 Ruiter DJ, Spatz A, van den Oord JJ, Cook MG. Pathologic staging of melanoma. Seminars in Oncology. 29: 370-81. PMID 12170440 DOI: 10.1053/Sonc.2002.34116  0.344
2002 Cook MG, Spatz A, Bröcker EB, Ruiter DJ. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. The Journal of Pathology. 197: 188-93. PMID 12015742 DOI: 10.1002/Path.1093  0.332
2002 van Dijk MC, Rombout PD, Mooi WJ, van de Molengraft FJ, van Krieken JH, Ruiter DJ, Ligtenberg MJ. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours. The Journal of Pathology. 197: 170-8. PMID 12015740 DOI: 10.1002/Path.1119  0.367
2002 Brochez L, Verhaeghe E, Grosshans E, Haneke E, Piérard G, Ruiter D, Naeyaert JM. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions Journal of Pathology. 196: 459-466. PMID 11920743 DOI: 10.1002/Path.1061  0.343
2002 de Wit NJ, Weidle UH, Ruiter DJ, van Muijen GN. Expression profiling of MMA-1a and splice variant MMA-1b: new cancer/testis antigens identified in human melanoma. International Journal of Cancer. Journal International Du Cancer. 98: 547-53. PMID 11920614 DOI: 10.1002/Ijc.10241  0.31
2002 Zendman AJ, van Kraats AA, den Hollander AI, Weidle UH, Ruiter DJ, van Muijen GN. Characterization of XAGE-1b, a short major transcript of cancer/testis-associated gene XAGE-1, induced in melanoma metastasis. International Journal of Cancer. Journal International Du Cancer. 97: 195-204. PMID 11774264 DOI: 10.1002/Ijc.1584  0.356
2001 Ruiter DJ, van Krieken JH, van Muijen GN, de Waal RM. Tumour metastasis: is tissue an issue? The Lancet. Oncology. 2: 109-12. PMID 11905791 DOI: 10.1016/S1470-2045(00)00229-1  0.337
2001 Ksters B, Westphal JR, Smits D, Ruiter DJ, Wesseling P, Keilholz U, De Waal RMW. The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin αvβ3 expression International Journal of Cancer. 92: 176-180. PMID 11291042 DOI: 10.1002/1097-0215(200102)9999:9999<::Aid-Ijc1173>3.0.Co;2-L  0.346
2001 Leenders W, Van Altena M, Lubsen N, Ruiter D, De Waal R. In vivo activities of mutants of vascular endothelial growth factor (VEGF) with differential in vitro activities International Journal of Cancer. 91: 327-333. PMID 11169955 DOI: 10.1002/1097-0215(200002)9999:9999<::Aid-Ijc1052>3.3.Co;2-N  0.305
2001 De Vries TJ, Smeets M, De Graaf R, Hou-Jensen K, Bröcker EB, Renard N, Eggermont AMM, Van Muijen GNP, Ruiter DJ. Expression of gp100, MART-I, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: Implications for diagnosis and immunotherapy. A study conducted by the EORTC melanoma cooperative group Journal of Pathology. 193: 13-20. PMID 11169510 DOI: 10.1002/1096-9896(2000)9999:9999<::Aid-Path729>3.0.Co;2-D  0.367
2000 Hofmann UB, Westphal JR, Waas ET, Becker JC, Ruiter DJ, Van Muijen GNP. Coexpression of integrin α(v)β 3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: Correlation with melanoma progression Journal of Investigative Dermatology. 115: 625-632. PMID 10998134 DOI: 10.1046/J.1523-1747.2000.00114.X  0.31
2000 Hofmann UB, Westphal JR, Van Muijen GNP, Ruiter DJ. Matrix metalloproteinases in human melanoma Journal of Investigative Dermatology. 115: 337-344. PMID 10951266 DOI: 10.1046/J.1523-1747.2000.00068.X  0.308
2000 Westphal JR, Van't Hullenaar R, Peek R, Willems RW, Crickard K, Crickard U, Askaa J, Clemmensen I, Ruiter DJ, De Waal RMW. Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo International Journal of Cancer. 86: 768-776. PMID 10842189 DOI: 10.1002/(Sici)1097-0215(20000615)86:6<768::Aid-Ijc3>3.0.Co;2-E  0.346
2000 Westphal JR, Van't Hullenaar R, Geurts-Moespot A, Sweep FCJG, Verheijen JH, Bussemakers MMG, Askaa J, Clemmensen I, Eggermont AAM, Ruiter DJ, De Waal RMW. Angiostatin generation by human tumor cell lines: Involvement of plasminogen activators International Journal of Cancer. 86: 760-767. PMID 10842188 DOI: 10.1002/(Sici)1097-0215(20000615)86:6<760::Aid-Ijc2>3.0.Co;2-4  0.334
1999 Ruijter ETG, Miller GJ, Van De Kaa CA, Van Bokhoven A, Bussemakers MJG, Debruyne FMJ, Ruiter DJ, Schalken JA. Molecular analysis of multifocal prostate cancer lesions Journal of Pathology. 188: 271-277. PMID 10419595 DOI: 10.1002/(Sici)1096-9896(199907)188:3<271::Aid-Path359>3.0.Co;2-K  0.315
1999 Zendman AJW, Cornelissen IMHA, Weidle UH, Ruiter DJ, Van Muijen GNP. TM7XN1, a novel human EGF-TM7-like cDNA, detected with mRNA differential display using human melanoma cell lines with different metastatic potential Febs Letters. 446: 292-298. PMID 10100861 DOI: 10.1016/S0014-5793(99)00230-6  0.327
1998 Ruiter DJ, Van Muijen GNP. Markers of melanocytic tumour progression Journal of Pathology. 186: 340-342. PMID 10209480 DOI: 10.1002/(Sici)1096-9896(199812)186:4<340::Aid-Path182>3.0.Co;2-K  0.35
1998 Ferrier CM, Van Geloof WL, De Witte HH, Kramer MD, Ruiter DJ, Van Muijen GNP. Epitopes of components of the plasminogen activation system are re- exposed in formalin-fixed paraffin sections by different retrieval techniques Journal of Histochemistry and Cytochemistry. 46: 469-476. PMID 9524192 DOI: 10.1016/S0268-9499(97)80304-9  0.311
1997 Wesseling P, Ruiter DJ, Burger PC. Angiogenesis in brain tumors; pathobiological and clinical aspects. Journal of Neuro-Oncology. 32: 253-65. PMID 9049887 DOI: 10.1023/A:1005746320099  0.317
1997 Scheibenbogen C, Weyers I, Ruiter D, Willhauck M, Bittinger A, Keilholz U. Expression of gp100 in melanoma metastases resected before or after treatment with IFN alpha and IL-2. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 19: 375-80. PMID 8941877 DOI: 10.1097/00002371-199609000-00007  0.323
1996 Spatz A, Ruiter D, Hardmeier T, Renard N, Wechsler J, Bailly C, Avril MF, Kwee H, Bastian BC, Hill C, De Potter C, Prade M. Melanoma in childhood: An EORTC-MCG multicenter study on the clinico-pathological aspects International Journal of Cancer. 68: 317-324. PMID 8903473 DOI: 10.1002/(Sici)1097-0215(19961104)68:3<317::Aid-Ijc9>3.0.Co;2-4  0.326
1996 Schlingemann RO, Oosterwijk E, Wesseling P, Rietveld FJR, Ruiter DJ. Aminopeptidase A is a constituent of activated pericytes in angiogenesis Journal of Pathology. 179: 436-442. PMID 8869294 DOI: 10.1002/(Sici)1096-9896(199608)179:4<436::Aid-Path611>3.0.Co;2-A  0.317
1996 Erhard H, Rietveld FJR, Bröcker EB, De Waal RMW, Ruiter DJ. Phenotype of Normal Cutaneous Microvasculature: Immunoelectron microscopic observations with emphasis on the differences between blood vessels and lymphatics Journal of Investigative Dermatology. 106: 135-140. PMID 8592064 DOI: 10.1111/1523-1747.Ep12329708  0.306
1995 Weterman MAJ, Ajubi N, Dinter IMRv, Degen WGJ, Muijen GNPv, Ruiter DJ, Bloemers HPJ. NMB, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts International Journal of Cancer. 60: 73-81. PMID 7814155 DOI: 10.1002/Ijc.2910600111  0.347
1995 Wesseling P, Schlingemann RO, Rietveld FJ, Link M, Burger PC, Ruiter DJ. Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study. Journal of Neuropathology and Experimental Neurology. 54: 304-10. PMID 7745429 DOI: 10.1097/00005072-199505000-00003  0.315
1994 De Wit PE, Kerstens HM, Poddighe PJ, Van Muijen GN, Ruiter DJ. DNA in situ hybridization as a diagnostic tool in the discrimination of melanoma and Spitz naevus. The Journal of Pathology. 173: 227-33. PMID 7931843 DOI: 10.1002/Path.1711730305  0.33
1994 Wesseling P, van der Laak JA, de Leeuw H, Ruiter DJ, Burger PC. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. Journal of Neurosurgery. 81: 902-9. PMID 7525899 DOI: 10.3171/Jns.1994.81.6.0902  0.325
1993 de Wit PEJ, van't Hof-Grootenboer B, Ruiter DJ, Bondi R, Bröcker EB, Cesarini JP, Hastrup N, Hou-Jensen K, MacKie RM, Scheffer E, Suter L, Urso C. Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group European Journal of Cancer. 29: 831-839. PMID 8484972 DOI: 10.1016/S0959-8049(05)80419-8  0.31
1993 Weterman MA, van Muijen GN, Ruiter DJ, Bloemers HP. Thymosin beta-10 expression in melanoma cell lines and melanocytic lesions: a new progression marker for human cutaneous melanoma. International Journal of Cancer. 53: 278-84. PMID 8425765 DOI: 10.1002/Ijc.2910530218  0.321
1993 Westphal JR, Willems HW, Schalkwijk CJ, Ruiter DJ, de Waal RM. A new 180-kDa dermal endothelial cell activation antigen: in vitro and in situ characteristics. The Journal of Investigative Dermatology. 100: 27-34. PMID 8423388 DOI: 10.1111/1523-1747.Ep12349946  0.336
1993 Mattijssen V, Mulder PHMD, Peters HM, Schalkwijk L, Hof-Grootenboer BV, Ruiter DJ, Manni JJ. E‐cadherin expression in head and neck squamous‐cell carcinoma is associated with clinical outcome International Journal of Cancer. 55: 580-585. PMID 8406985 DOI: 10.1002/Ijc.2910550411  0.365
1993 Goerdt S, Bröcker EB, Redmann K, Ruiter DJ, Gullotta F, Bergmann M, Dämmrich J, Buchholz B, Dietl KH, Göters C. Monoclonal antibody MS-44B reacts with human dendritic, glial and endothelial cells: differential expression of MS-44B antigen by epidermal dendritic cells and by MS-1+ splenic sinusoidal endothelial cells. An immunohistological study. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 61: 36-42. PMID 8216821 DOI: 10.1159/000163758  0.306
1993 Wesseling P, Vandersteenhoven JJ, Downey BT, Ruiter DJ, Burger PC. Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms. A light microscopic and immunohistochemical study of formalin-fixed, routinely processed material. Acta Neuropathologica. 85: 508-14. PMID 7684179 DOI: 10.1007/Bf00230490  0.328
1992 de Jong EM, van Erp PE, Ruiter DJ, van de Kerkhof PC. Immunohistochemical detection of proliferation and differentiation in discoid lupus erythematosus. Journal of the American Academy of Dermatology. 25: 1032-8. PMID 1725780 DOI: 10.1016/0190-9622(91)70303-J  0.335
1992 Mattijssen V, Van Moorselaar J, De Mulder PH, Schalkwijk L, Ruiter DJ. Human leukocyte antigen expression in renal cell carcinoma lesions does not predict the response to interferon therapy. Journal of Immunotherapy : Official Journal of the Society For Biological Therapy. 12: 64-9. PMID 1637784 DOI: 10.1097/00002371-199207000-00008  0.37
1992 de Wit PE, Moretti S, Koenders PG, Weterman MA, van Muijen GN, Gianotti B, Ruiter DJ. Increasing epidermal growth factor receptor expression in human melanocytic tumor progression. The Journal of Investigative Dermatology. 99: 168-73. PMID 1629628 DOI: 10.1111/1523-1747.Ep12616793  0.38
1992 de Wit PE, Hopman AH, van Muijen GN, Smeets DF, Beck JL, Moesker O, Ruiter DJ. In situ detection of supernumerary aberrations of chromosome-specific repetitive DNA targets in interphase nuclei in human melanoma cell lines and tissue sections. The Journal of Investigative Dermatology. 98: 450-8. PMID 1548428 DOI: 10.1111/1523-1747.Ep12499853  0.348
1992 Bröcker EB, Reckenfeld C, Hamm H, Ruiter DJ, Sorg C. Macrophages in melanocytic naevi. Archives of Dermatological Research. 284: 127-31. PMID 1380230 DOI: 10.1007/Bf00372703  0.314
1991 Mattijssen V, Mulder PHMd, Schalkwijk L, Manni JJ, Hof-Grootenboer BV, Ruiter DJ. HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites International Journal of Cancer. 47: 95-100. PMID 2066187 DOI: 10.1002/Ijc.2910470719  0.351
1991 van Muijen GN, Jansen KF, Cornelissen IM, Smeets DF, Beck JL, Ruiter DJ. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. International Journal of Cancer. 48: 85-91. PMID 2019461 DOI: 10.1002/Ijc.2910480116  0.334
1991 Mattijssen V, De Mulder PH, Schornagel JH, Verweij J, Van den Broek P, Galazka A, Roy S, Ruiter DJ. Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinoma. Journal of Immunotherapy : Official Journal of the Society For Biological Therapy. 10: 63-8. PMID 2012800 DOI: 10.1097/00002371-199102000-00009  0.348
1990 van Muijen GN, Ruiter DJ, Hoefakker S, Johnson JP. Monoclonal antibody PAL-M1 recognizes the transferrin receptor and is a progression marker in melanocytic lesions. The Journal of Investigative Dermatology. 95: 65-9. PMID 2366002 DOI: 10.1111/1523-1747.Ep12873947  0.309
1989 Steijlen PM, Hamm H, van Erp EJ, Johnson JP, Ruiter DJ, Bröcker EB. Immunohistologic evidence for the malignant potential of congenital melanocytic nevi. The Journal of Investigative Dermatology. 92: 366-70. PMID 2645372 DOI: 10.1111/1523-1747.Ep12277206  0.389
1989 Ruiter DJ, Schlingemann RO, Rietveld FJ, de Waal RM. Monoclonal Antibody-Defined Human Endothelial Antigens as Vascular Markers Journal of Investigative Dermatology. 93: S25-S32. DOI: 10.1038/Jid.1989.5  0.31
1988 van Vreeswijk H, Ruiter DJ, Bröcker EB, Welvaart K, Ferrone S. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma. The Journal of Investigative Dermatology. 90: 755-60. PMID 3283252 DOI: 10.1111/1523-1747.Ep12560951  0.336
1987 Holzmann B, Bröcker EB, Lehmann JM, Ruiter DJ, Sorg C, Riethmüller G, Johnson JP. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes. International Journal of Cancer. 39: 466-71. PMID 3104215 DOI: 10.1002/Ijc.2910390410  0.401
1986 Ruiter DJ, Brocker EB, Ferrone S. Expression and susceptibility to modulation by interferons of HLA class I and II antigens on melanoma cells. Immunohistochemical analysis and clinical relevance Journal of Immunogenetics. 13: 229-234. PMID 2434574 DOI: 10.1111/J.1744-313X.1986.Tb01105.X  0.342
1985 Ruiter DJ, Dingjan GM, Steijlen PM, van Beveren-Hooyer M, de Graaff-Reitsma C, Bergman W, van Muijen GN, Warnaar SO. Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi. The Journal of Investigative Dermatology. 85: 4-8. PMID 3891875 DOI: 10.1111/1523-1747.Ep12274479  0.3
1985 van Muijen GN, Ruiter DJ, Warnaar SO. Intermediate filaments in Merkel cell tumors. Human Pathology. 16: 590-5. PMID 3888816 DOI: 10.1016/S0046-8177(85)80108-8  0.351
1985 Bergman W, Willemze R, de Graaff-Reitsma C, Ruiter DJ. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi. The Journal of Investigative Dermatology. 85: 25-9. PMID 3159801 DOI: 10.1111/1523-1747.Ep12274521  0.321
1984 Suter L, Bröcker EB, Brüggen J, Ruiter DJ, Sorg C. Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies. Cancer Immunology, Immunotherapy : Cii. 16: 53-8. PMID 6556951 DOI: 10.1007/Bf00199906  0.368
1984 Duinen SGv, Ruiter DJ, Hageman P, Vennegoor C, Dickersin GR, Scheffer E, Rümke P. Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma Cancer. 53: 1566-1573. PMID 6365305 DOI: 10.1002/1097-0142(19840401)53:7<1566::Aid-Cncr2820530724>3.0.Co;2-9  0.386
1982 Willemze R, Ruiter DJ, Van Vloten WA, Meijer CJ. Reticulum cell sarcomas (large cell lymphomas) presenting in the skin. High frequency of true histiocytic lymphoma. Cancer. 50: 1367-79. PMID 7049350 DOI: 10.1002/1097-0142(19821001)50:7<1367::Aid-Cncr2820500724>3.0.Co;2-4  0.333
1980 Willemze R, Ruiter DJ, Scheffer E, Vloten WA. Diffuse cutaneous mastocytosis with multiple cutaneous mastocytomas. Report of a case with clinical, histopathological and ultrastructural aspects. British Journal of Dermatology. 102: 601-607. PMID 6770887 DOI: 10.1111/J.1365-2133.1980.Tb07663.X  0.312
Show low-probability matches.